AnalystsInsight

Michael Genovese (Rosenblatt Securities): Analyst Track Record and Price‑Target Accuracy

How often Michael Genovese’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 831 ratings, compared with the average Wall Street analyst.

Published Updated 3 min readHow we research

What changed since Oct 12

Exent re-checks this page every day. Ratings appear 30 days after they are published; live calls are in Gems.

#137 rank (was #141)+3 new ratings (CIEN, NOK, RBBN)1 downgrade+1 stock newly covered61.3% price‑target hit rate (was 62.9%)

Key takeaways

  • Michael Genovese ranks #137 of 1,121 analysts in Exent’s scoring (5.0★).
  • 61.3% of price targets were reached over 7 years, versus 53.6% for the average analyst.
  • Median time to reach a target: 70 days; 64.3% of calls were up 12 months later.
  • Most‑covered stocks: AAOI, CIEN, LITE, COHR.
  • Michael published 1 rating in the last 30 days, the latest on Sep 23, 2026.

Michael Genovese’s track record at a glance

Michael Genovese of Rosenblatt Securities ranks #137 of the 1,121 analysts Exent scores, with a 5.0★ rating and a focus on technology. Over a 7‑year lookback, 61.3% of Michael’s price targets were reached, 7.7 points above the 53.6% average across all analysts.

MetricMichael GenoveseAll analysts
Price‑target hit rate61.3%53.6%
Median days to hit target70 days91 days
Calls up after 12 months64.3%64.6%
Median 12‑month return of calls+18.7%+13.4%
Hit rate, last 2 years77.8%—
Average worst drop after a call−21.2%—
Ratings in the sample831—
Stocks covered18—

The full records of Exent’s top 90 analysts and the top 50 of each sector, and the stocks where several of them agree right now, are members‑only in Exent Gems.

How fast price targets were reached

Time to reach the targetMichael Genovese
Under 30 days18.4%
30–90 days39.0%
90–180 days19.2%
Over 180 days23.4%

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks Michael Genovese covers most

StockRatings in the sample
AAOI45
CIEN43
LITE39
COHR34
ANET33
VIAV32
EXTR29
CALX27

In the past year Michael’s ratings were 84% Buy, 16% Hold and 0% Sell.

Michael Genovese’s latest ratings

DateStockActionRatingPrice target
Sep 23, 2026
Sep 17, 2026CIENReiterated: BuyBuy$525.00
Sep 15, 2026NOKInitiated Coverage: BuyBuy$15.00
Sep 15, 2026RBBNDowngraded: HoldHold$2.20
Sep 3, 2026CIENReiterated: BuyBuy$525.00
Sep 2, 2026CRDOReiterated: HoldHold$235.00
Aug 23, 2026CRDOReiterated: HoldHold$215.00
Aug 23, 2026CIENReiterated: BuyBuy$720.00
Aug 20, 2026FNReiterated: BuyBuy$750.00
Aug 19, 2026LITEReiterated: BuyBuy$1300.00
Aug 19, 2026VIAVReiterated: BuyBuy$70.00
Aug 19, 2026AAOIReiterated: BuyBuy$220.00
Aug 19, 2026COHRReiterated: BuyBuy$500.00
  • Sep 23, 2026
    Stock
    Action
    Rating
    Price target
  • Sep 17, 2026
    Stock
    CIEN
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $525.00
  • Sep 15, 2026
    Stock
    NOK
    Action
    Initiated Coverage: Buy
    Rating
    Buy
    Price target
    $15.00
  • Sep 15, 2026
    Stock
    RBBN
    Action
    Downgraded: Hold
    Rating
    Hold
    Price target
    $2.20
  • Sep 3, 2026
    Stock
    CIEN
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $525.00
  • Sep 2, 2026
    Stock
    CRDO
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $235.00
  • Aug 23, 2026
    Stock
    CRDO
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $215.00
  • Aug 23, 2026
    Stock
    CIEN
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $720.00
  • Aug 20, 2026
    Stock
    FN
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $750.00
  • Aug 19, 2026
    Stock
    LITE
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $1300.00
  • Aug 19, 2026
    Stock
    VIAV
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $70.00
  • Aug 19, 2026
    Stock
    AAOI
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $220.00
  • Aug 19, 2026
    Stock
    COHR
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $500.00

Michael published 1 rating in the last 30 days, the latest on Sep 23, 2026. Ratings from the last 30 days are members‑only in Exent Gems, with the stocks where several top‑ranked analysts agree; older ratings are shown in full.

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Oct 20, 2026; ranking updated Oct 21, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

  1. Exent Gems shows Michael Genovese’s live ratings and those of the top‑ranked analysts, without the 30‑day delay used on this page.
  2. Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
  3. Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring Michael Genovese ranks #137 of 1,121 with a 5.0★ rating. 61.3% of price targets were reached over a 7-year lookback (all analysts: 53.6%), and 64.3% of calls were up 12 months later. Past accuracy does not guarantee future accuracy.

Michael Genovese’s success rate is 53.4% by the ranking source and 61.3% by Exent’s price-target hit-rate backtest, with a median of 70 days to reach a target.

Michael Genovese (Rosenblatt Securities) covers 18 stocks, mostly in technology. The most frequently rated are AAOI, CIEN, LITE, COHR, ANET.

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.